Literature DB >> 9413422

The pharmacologic rationale for the clinical use of antidepressants.

R M Pinder.   

Abstract

Mesh:

Substances:

Year:  1997        PMID: 9413422     DOI: 10.4088/jcp.v58n1108

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


× No keyword cloud information.
  7 in total

1.  Antidepressant- and anxiolytic effects of the novel melatonin agonist Neu-P11 in rodent models.

Authors:  Shao-wen Tian; Moshe Laudon; Li Han; Jun Gao; Fu-lian Huang; Yu-feng Yang; Hai-feng Deng
Journal:  Acta Pharmacol Sin       Date:  2010-06-28       Impact factor: 6.150

Review 2.  Mirtazapine: a review of its use in major depression.

Authors:  K J Holm; A Markham
Journal:  Drugs       Date:  1999-04       Impact factor: 9.546

3.  [N-methyl-11C]Mirtazapine for positron emission tomography neuroimaging of antidepressant actions in humans.

Authors:  Katalin Marthi; Steen Jakobsen; Dirk Bender; Søren B Hansen; Stefan Bo Smith; Flemming Hermansen; Raben Rosenberg; Donald F Smith
Journal:  Psychopharmacology (Berl)       Date:  2004-07       Impact factor: 4.530

Review 4.  Mirtazapine: a review of its use in major depression and other psychiatric disorders.

Authors:  Katherine F Croom; Caroline M Perry; Greg L Plosker
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

Review 5.  New formulations of existing antidepressants: advantages in the management of depression.

Authors:  Trevor R Norman; James S Olver
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 6.  Therapeutic effects of melatonin receptor agonists on sleep and comorbid disorders.

Authors:  Moshe Laudon; Anat Frydman-Marom
Journal:  Int J Mol Sci       Date:  2014-09-09       Impact factor: 5.923

7.  Effect of five-consecutive-day exposure to an anxiogenic stressor on sleep-wake activity in rats.

Authors:  Matthew W O'Malley; Rachel Lea Fishman; Domenic A Ciraulo; Subimal Datta
Journal:  Front Neurol       Date:  2013-02-26       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.